Lung cancer in never-smokers
Open Access
- 5 July 2006
- journal article
- review article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 60 (4), 337-340
- https://doi.org/10.1136/jcp.2006.040576
Abstract
The mystery behind never‐smokers being more prone to lung cancer is unlocked with regard to smoking status and sexKeywords
This publication has 45 references indexed in Scilit:
- Mutational and Epigenetic Evidence for Independent Pathways for Lung Adenocarcinomas Arising in Smokers and Never SmokersCancer Research, 2006
- Erlotinib in Lung Cancer — Molecular and Clinical Predictors of OutcomeThe New England Journal of Medicine, 2005
- Lung cancer death rates by smoking status: Comparison of the Three‐Prefecture Cohort study in Japan to the Cancer Prevention Study II in the USACancer Science, 2005
- A Major Lung Cancer Susceptibility Locus Maps to Chromosome 6q23–25American Journal of Human Genetics, 2004
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences of the United States of America, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibThe New England Journal of Medicine, 2004
- The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in TaiwanCancer, 2003
- Occupation and Lung Cancer in Non-SmokersReviews on Environmental Health, 2003
- Increased cancer risk among relatives of nonsmoking lung cancer casesGenetic Epidemiology, 1999